Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2

Antiviral Therapy

Volumn 16, Issue 8, 2011, Pages 1297-1308

  Sauerbrei, Andreas ^a   Bohn, Kathrin ^a   Heim, Albert ^b   Hofmann, Jörg ^c   Weißbrich, Benedikt ^d   Schnitzler, Paul ^e   Hoffmann, Dieter ^f   Zell, Roland ^a   Jahn, Gerhard ^g   Wutzler, Peter ^a   Hamprecht, Klaus ^g  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CIDOFOVIR; FOSCARNET; FOSCARNET SODIUM; PENCICLOVIR;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DNA POLYMERASE GENE; FEMALE; FRAMESHIFT MUTATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC DATABASE; GENOTYPE PHENOTYPE CORRELATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IC 50; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYMIDINE KINASE GENE; VIRUS ISOLATION; VIRUS STRAIN;

ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BROMODEOXYURIDINE; CHILD; CHILD, PRESCHOOL; CYTOSINE; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; FEMALE; FOSCARNET; GENOTYPE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PHOSPHONIC ACIDS; SEQUENCE ANALYSIS, DNA; THYMIDINE KINASE; VIRAL PROTEINS;

EID: 83455199998     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1870     Document Type: Article

References (38)

1. Stanberry LR, Floyd-Reising SA, Connelly BL, et al. Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis 1994; 18:401-407. (Pubitemid 24086312)
2. Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 1982; 97:813-820. (Pubitemid 13240560)
3. Johnson JR, Egaas S, Gleaves CA, Hackman R, Bowden RA. Hepatitis due to herpes simplex virus in marrow-transplant recipients. Clin Infect Dis 1992; 14:38-45.
4. Kaufman B, Gandhi SA, Louie E, Rizzi R, Illei P. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis 1997; 24:334-338. (Pubitemid 27096784)
5. Collins P, Ellis MN. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol 1993; 41 Suppl 1:58-66. (Pubitemid 23290485)
6. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004; 42:242-249. (Pubitemid 38082727)
7. Englund JA, Zimmermann ME, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH. Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med 1990; 112:416-422. (Pubitemid 20098522)
8. Illán H, Jacob N, Maiolo E, Cisterna D, Schiavelli R, Freire MC. Antiviral sensitivity of herpes simplex virus in immunocompromised patients. Rev Argent Microbiol 2004; 36:88-91. (Pubitemid 39180810)
9. Chakrabarti S, Pillay D, Ratcliffe D, Cane PA, Collingham KE, Milligan DW. Resistance to antiviral drugs in herpes simplex virus infections among allogenic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 2000; 181:2055-2058. (Pubitemid 30416174)
10. Bestman-Smith J, Schmitt I, Papadopoulou B, Boivin G. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J Virol 2001; 75:3105-3110. (Pubitemid 32225874)
11. Morfin F, Thouvenout D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26:29-37. (Pubitemid 36183346)
12. Larder BA, Darby G. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology 1985; 146:262-271. (Pubitemid 16240381)
13. Safrin S, Asseykeen T, Follansbee S, Mills J. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis 1990; 161:1078-1084. (Pubitemid 20177863)
14. Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol 2006; 7:13-29.
15. Wyles DL, Patel A, Madinger N, Bessesen M, Krause PR, Weinberg A. Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin Infect Dis 2005; 41:676-680. (Pubitemid 41170356)
16. Sauerbrei A, Eichhorn U, Hottenrott G, Wutzler P. Virological diagnosis of herpes simplex encephalitis. J Clin Virol 2000; 17:31-36. (Pubitemid 30256289)
17. Balfour HH, Jr., Benson C, Braun J, et al. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 1994; 7:254-260.
18. Sauerbrei A, Deinhardt S, Zell R, Wutzler P. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus. Antiviral Res 2010; 86:246-252.
19. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991; 325:551-555.
20. McGeoch DJ, Dolan A, Donald S, Rixon FJ. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol 1985; 181:1-13. (Pubitemid 16217352)
21. McGeoch DJ, Moss HW, McNab D, Frame MC. DNA sequence and genetic content of the Hind III 1 region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparison. J Gen Virol 1987; 68:19-38. (Pubitemid 17207186)
22. Suzutani T, Ishioka K, De Clercq E, et al. Differential mutation pattern in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother 2003; 47:1707-1713. (Pubitemid 36548558)
23. Bohn K, Zell R, Schacke M, Wutzler P, Sauerbrei A. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus. Antivir Ther doi: 10.3851/IMP1852.
24. Fyfe JA. Differential phosphorylation of (E)-5(2-bromovinyl)-2′- deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella-zoster virus. Mol Pharmacol 1982; 21:432-437. (Pubitemid 12139845)
25. Sarisky RT, Quail MR, Clark PE, et al. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir and acyclovir. J Virol 2001; 75:1761-1769. (Pubitemid 32110165)
26. Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus. Dermatol Clin 2003; 21:311-320. (Pubitemid 36529765)
27. Gaudreau A, Hill E, Balfour HH, Jr., Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998; 178:297-303. (Pubitemid 28347909)
28. Frobert E, Cortay JC, Ooka T, et al. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res 2008; 79:28-36.
29. Chibo D, Druce J, Sasadeusz J, Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res 2004; 61:83-91. (Pubitemid 37506095)
30. Morfin F, Souillet G, Bilger K, Ooka T, Aymard M, Thouvenot D. Genetic characterization of thymindine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J Infect Dis 2000; 182:290-293. (Pubitemid 30497816)
31. Saijo M, Suzutani T, De Clercq E, et al. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res 2002; 56:253-262. (Pubitemid 35284298)
32. Bae PK, Kim JH, Kim HS, Chung IK, Paik SG, Lee CK. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1. Antiviral Res 2006; 70:93-104. (Pubitemid 43765619)
33. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist Updat 2002; 5:88-114. (Pubitemid 35024271)
34. Larder BA, Kemp SD, Darby G. Related functional domains in virus DNA polymerases. EMBO J 1987; 6:169-175.
35. Burrel S, Deback C, Agut H, Boutolleau D. Genotypic characterization of UL23 thymindine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother 2010; 54:4833-4842.
36. Stránská R, Schuurman R, Nienhuis E, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005; 32:7-18. (Pubitemid 39575009)
37. Duan R, de Vries RD, van Dun JM, et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. J Infect Dis 2009; 200:1402-1414.
38. Chevillotte M, von Einem J, Meier BM, Lin FM, Kestler HA, Mertens T. A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes. Antiviral Res 2010; 85:318-327.